"Normal Coronary Artery" With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

EARLY_PHASE1

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators will investigate patients undergoing coronary angiography with normal coronary but slow blood flow that was normalized after adenosine injection into the coronary artery. The investigators believe that they have small vessel coronary disease which is the initial presentation of coronary disease prior to anatomical narrowing. To alleviate this phenomenon the investigators intend to examine the long-term clinical response of these patients to treatment with dipyridamole, a well-known medication with almost no side-effects that increases the level of adenosine in the tissue.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Characterization of Slow Coronary Flow

NCT02025101

Cardiovascular Abnormalities Vascular Diseases

UNKNOWN

Slow Coronary Artery Flow: Influence on Morbidity and Mortality

NCT00603226

Coronary Disease

UNKNOWN

Vitamin D Supplementation Can Improve Heart Function in Idiopathic Cardiomyopathy

NCT02517814

Cardiomyopathy, Dilated

UNKNOWN NA

Subclinical Hypothyroidism and Acute Anterior Myocardial Infarction: Is it Cardio-protective or Not?

NCT03017157

Heart Injuries

UNKNOWN

Endothelial Function-guided Therapy Compared to Usual Care in Patients With NOCAD

NCT02313987

Coronary Atherosclerosis

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Angiography

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1. Routine treatment

Control group

Group Type ACTIVE_COMPARATOR

Statin, aspirin

Intervention Type DRUG

2. Dipyridamole treatment

Group that receives Dipyridamole treatment

Group Type EXPERIMENTAL

Dipyridamole

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Statin, aspirin

Intervention Type DRUG

Dipyridamole

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing coronary angiography and who have normal coronary artery with slow blood flow that normalized with adenosine injection into the coronary artery